First Patient Enrolled in Palatin's Phase 2 study of PL8177 in Ulcerative Colitis Trial

Retrieved on: 2022-10-20 12:30:08

Tags for this article:

Click the tags to see associated articles and topics

First Patient Enrolled in Palatin's Phase 2 study of PL8177 in Ulcerative Colitis Trial. View article details on hiswai:

Excerpt

... ("MCr") system has effects on inflammation, immune system responses, ... biopharmaceutical and biotechnology companies, commercial acceptance ...

Article found on: www.biospace.com